Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$16.42 -0.10 (-0.61%)
At close: Sep 29, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) EV to EBITDA (2024 - 2026)

Updated

Aurinia Pharmaceuticals' (AUPH) EV to EBITDA was 10.65 for Q2 2026, down 5.8% from 11.31 a year earlier and down 1.7% from the prior quarter.

Analysis

Aurinia Pharmaceuticals (AUPH) EV to EBITDA (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Aurinia Pharmaceuticals' EV to EBITDA came in at 4.02; for FY2025, it came in at 13.77, down 77.6% from FY2024.

  • By year, EV to EBITDA came in at 61.43 in FY2024.
  • Year over year, EV to EBITDA has now declined in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 10.84 (Q1 2026), 13.77 (Q4 2025) and 12.35 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Aurinia Pharmaceuticals 2.20 Bn 623.91 Mn 76.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.65
Mar 31, 2026 10.84
Dec 31, 2025 13.77
Sep 30, 2025 12.35
Jun 30, 2025 11.31
Mar 31, 2025 15.93
Dec 31, 2024 61.43
API Access

Aurinia Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AUPH&period=max&api_key=YOUR_API_KEY